Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (490)	3/2/2005 2:49:54 PM
From: Ian@SI	Read Replies (2) of 946

Thanks for the detailed reply and background. I guess my biggest disappointment was Theratope where the CEO, even after the failure, remains quite optimistic. So optimistic that he's playing the same movie once again, this time with BLP-25. {BIOM} The option which Bianco offered and then shot down was that all patients were tolerating higher doses; that the survival may just be due to higher concentrations of drug in both arms. Even in that unlikely circumstance, Xyotax would still show superiourity due to lower toxicity. I believe Bianco now expects to issue the PR next week - the shorter it is, the better the results. So even next week, we're still not going to know how good it was. Wait for ASCO seems to be the timing for that answer. Best regards, Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next